Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZCP, also known as Zero Copay Program, is a private U.S. healthcare services and health technology company focused on pharmaceutical claims processing, pharmacy benefit administration, and related marketing solutions. The company positions itself as a pass-through PBA/PBM serving pharmaceutical manufacturers, copay assistance programs, third-party administrators, and other healthcare stakeholders. Its core offering is the proprietary InfinityRx Claims Processor platform, which supports high-volume claim adjudication, real-time transaction visibility, customized analytics, and connectivity to a broad U.S. retail pharmacy network. ZCP also markets the Infinity Brand Loyalty platform, a toolkit intended to support manufacturer programs and employee benefit offerings. Based on available public information, ZCP appears to be an operating commercial-stage healthcare company rather than a drug developer, with no disclosed therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZCP.